ROBERT P ROCHE JR Insider Trading $ATRS ANTARES PHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT P ROCHE JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT P ROCHE JR. ROBERT P ROCHE JR is Director in ANTARES PHARMA, INC. ($ATRS) and Director in ARATANA THERAPEUTICS, INC. ($PETX) and Director in Egalet Corp ($EGLT).
ROBERT P ROCHE JR in ANTARES PHARMA, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT P ROCHE JR: Director
Holdings: 142,365 shares
Current Value: $313,203
Latest Transaction: Jun 15 2020
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT P ROCHE JR in ANTARES PHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRS, PETX, EGLT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.73 | 58,246 | 159,012 | 58,246 | |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Grant | A | 2.73 | 30,220 | 82,501 | 142,365 | 112.1 K to 142.4 K (+26.95 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Grant | A | 2.92 | 23,973 | 70,001 | 112,145 | 88.2 K to 112.1 K (+27.19 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 | |
| Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 1.12 | 150,000 | 168,000 | 150,000 | |
| Mar 22 2016 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Buy | P | 0.72 | 50,000 | 36,000 | 88,172 | 38.2 K to 88.2 K (+130.99 %) |
| Aug 25 2015 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Buy | P | 1.77 | 5,000 | 8,850 | 38,172 | 33.2 K to 38.2 K (+15.07 %) |
| Aug 17 2015 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Buy | P | 1.94 | 5,000 | 9,700 | 33,172 | 28.2 K to 33.2 K (+17.75 %) |
| Jun 19 2015 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.18 | 99,395 | 216,681 | 99,395 |
Page: 1